Selvinaz Dalaklıoğlu

456 total citations
21 papers, 384 citations indexed

About

Selvinaz Dalaklıoğlu is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Selvinaz Dalaklıoğlu has authored 21 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 5 papers in Psychiatry and Mental health. Recurrent topics in Selvinaz Dalaklıoğlu's work include Pain Mechanisms and Treatments (3 papers), Sexual function and dysfunction studies (3 papers) and PARP inhibition in cancer therapy (3 papers). Selvinaz Dalaklıoğlu is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Sexual function and dysfunction studies (3 papers) and PARP inhibition in cancer therapy (3 papers). Selvinaz Dalaklıoğlu collaborates with scholars based in Türkiye. Selvinaz Dalaklıoğlu's co-authors include Arda Taşatargil, Çiler Çelik-Özenci, Nurkan Aksoy, Gül Özbey, Sadi S. Özdem, Nazif Hikmet Aksoy, Sebahat Özdem, Nuray Erin and Gamze Tanrιöver and has published in prestigious journals such as Pharmacological Research, Toxicology Letters and Peptides.

In The Last Decade

Selvinaz Dalaklıoğlu

21 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selvinaz Dalaklıoğlu Türkiye 12 89 73 55 51 49 21 384
Kevser Tanbek Türkiye 14 106 1.2× 99 1.4× 53 1.0× 68 1.3× 26 0.5× 39 523
Yeşim Öztaş Türkiye 12 89 1.0× 122 1.7× 49 0.9× 58 1.1× 47 1.0× 50 511
Hatice Sezen Türkiye 12 53 0.6× 85 1.2× 22 0.4× 44 0.9× 24 0.5× 34 427
Mine Yavuz Taşlıpınar Türkiye 12 51 0.6× 63 0.9× 49 0.9× 47 0.9× 35 0.7× 18 410
Ebru Ofluoğlu Türkiye 15 86 1.0× 94 1.3× 36 0.7× 95 1.9× 78 1.6× 23 526
Mustafa Sağır Türkiye 11 97 1.1× 55 0.8× 29 0.5× 43 0.8× 26 0.5× 13 344
Entesar F. Amin Egypt 13 111 1.2× 155 2.1× 64 1.2× 46 0.9× 44 0.9× 15 583
Başar Sırmagül Türkiye 11 48 0.5× 88 1.2× 27 0.5× 49 1.0× 16 0.3× 37 426
Junjun Mao China 10 39 0.4× 110 1.5× 18 0.3× 50 1.0× 35 0.7× 19 495
Filiz Mercantepe Türkiye 11 103 1.2× 62 0.8× 18 0.3× 35 0.7× 20 0.4× 57 376

Countries citing papers authored by Selvinaz Dalaklıoğlu

Since Specialization
Citations

This map shows the geographic impact of Selvinaz Dalaklıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selvinaz Dalaklıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selvinaz Dalaklıoğlu more than expected).

Fields of papers citing papers by Selvinaz Dalaklıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selvinaz Dalaklıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selvinaz Dalaklıoğlu. The network helps show where Selvinaz Dalaklıoğlu may publish in the future.

Co-authorship network of co-authors of Selvinaz Dalaklıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Selvinaz Dalaklıoğlu. A scholar is included among the top collaborators of Selvinaz Dalaklıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selvinaz Dalaklıoğlu. Selvinaz Dalaklıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalaklıoğlu, Selvinaz, et al.. (2018). Protective effect of exendin-4 treatment on erectile dysfunction induced by chronic methylglyoxal administration in rats. Peptides. 106. 1–8. 10 indexed citations
2.
3.
Dalaklıoğlu, Selvinaz, et al.. (2016). Resveratrol Prevented Lipopolysaccharide-Induced Endothelial Dysfunction in Rat Thoracic Aorta Through Increased eNOS Expression. Balkan Medical Journal. 33(2). 138–143. 10 indexed citations
4.
Dalaklıoğlu, Selvinaz & Nuray Erin. (2016). Substance P Prevents Vascular Endothelial Dysfunction in Metastatic Breast Carcinoma. Protein and Peptide Letters. 23(11). 952–957. 3 indexed citations
5.
Dalaklıoğlu, Selvinaz, et al.. (2016). Resveratrol reverses diabetes-related decrement in sildenafil-induced relaxation of corpus cavernosum in aged rats. Aging Clinical and Experimental Research. 29(3). 345–351. 3 indexed citations
6.
Dalaklıoğlu, Selvinaz & Gül Özbey. (2014). Role of different types of potassium channels in the relaxation of corpus cavernosum induced by resveratrol. Pharmacognosy Magazine. 10(37). 47–47. 17 indexed citations
7.
8.
Dalaklıoğlu, Selvinaz. (2013). Evaluating Appropriateness of Digoxin, Carbamazepine, Valproic Acid, and Phenytoin Usage by Therapeutic Drug Monitoring. Clinical Laboratory. 59(03+04/2013). 325–31. 10 indexed citations
9.
Dalaklıoğlu, Selvinaz & Gül Özbey. (2013). The potent relaxant effect of resveratrol in rat corpus cavernosum and its underlying mechanisms. International Journal of Impotence Research. 25(5). 188–193. 14 indexed citations
10.
Dalaklıoğlu, Selvinaz, et al.. (2013). Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation. Human & Experimental Toxicology. 32(6). 662–671. 103 indexed citations
11.
Dalaklıoğlu, Selvinaz, et al.. (2013). Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase. Vascular Pharmacology. 59(3-4). 103–111. 10 indexed citations
12.
Dalaklıoğlu, Selvinaz, et al.. (2013). Chronic treatment with taurine ameliorates diabetes‐induced dysfunction of nitric oxide‐mediated neurogenic and endothelium‐dependent corpus cavernosum relaxation in rats. Fundamental and Clinical Pharmacology. 28(4). 394–404. 12 indexed citations
13.
Dalaklıoğlu, Selvinaz, et al.. (2013). Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats. The Aging Male. 17(4). 259–266. 15 indexed citations
14.
Dalaklıoğlu, Selvinaz, et al.. (2012). Potential Role of Poly(ADP-Ribose) Polymerase (PARP) Activation in Methotrexate-Induced Nephrotoxicity and Tubular Apoptosis. International Journal of Toxicology. 31(5). 430–440. 19 indexed citations
15.
Dalaklıoğlu, Selvinaz, et al.. (2009). Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicology Letters. 192(2). 91–96. 29 indexed citations
16.
Taşatargil, Arda, et al.. (2008). Poly (ADP-Ribose) Polymerase as a Potential Target for the Treatment of Acute Renal Injury Caused by Lipopolysaccharide. Renal Failure. 30(1). 115–120. 17 indexed citations
17.
Taşatargil, Arda, et al.. (2006). Effects of vitamin K1 supplementation on vascular responsiveness and oxidative stress in a rat femoral osteotomy model. Cell Biochemistry and Function. 25(5). 485–490. 8 indexed citations
18.
Taşatargil, Arda, et al.. (2005). Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta. Pharmacological Research. 51(6). 581–586. 12 indexed citations
19.
Taşatargil, Arda, et al.. (2005). Comparison of the Vasodilatory Effect of Nadroparin, Enoxaparin, Dalteparin, and Unfractioned Heparin in Human Internal Mammary Artery. Journal of Cardiovascular Pharmacology. 45(6). 550–554. 22 indexed citations
20.
Taşatargil, Arda, et al.. (2004). Poly(ADP-Ribose) Polymerase Inhibition Prevents Homocysteine-Induced Endothelial Dysfunction in the Isolated Rat Aorta. Pharmacology. 72(2). 99–105. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevser Tanbek Breakdown of academic impact, for papers by Yeşim Öztaş Breakdown of academic impact, for papers by Hatice Sezen Breakdown of academic impact, for papers by Mine Yavuz Taşlıpınar Breakdown of academic impact, for papers by Ebru Ofluoğlu Breakdown of academic impact, for papers by Mustafa Sağır Breakdown of academic impact, for papers by Entesar F. Amin Breakdown of academic impact, for papers by Başar Sırmagül Breakdown of academic impact, for papers by Junjun Mao Breakdown of academic impact, for papers by Filiz Mercantepe
Rankless by CCL
2026